Skip to content

Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy

Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP(Hepatobiliary and Pancreatic) Malignancy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02784353
Acronym
PReHeBP
Enrollment
158
Registered
2016-05-27
Start date
2016-10-04
Completion date
2021-05-24
Last updated
2022-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Tract Neoplasms, Hepatic Neoplasms, Pancreatic Neoplasms

Keywords

Rehabilitation, Quality of life, Surgery, Hepatic neoplasms, Biliary tract neoplasms, Pancreatic neoplasms

Brief summary

Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy.

Detailed description

The most important outcome in the management of HBP malignancies is survival. Since the application of ERAS (enhanced recovery after surgery), the improvement of QOL(quality of life) has been known as one of important factor for the management of HBP malignancies as well as survival, and the improvement of QOL, itself, affect the survival. There are several reports that perioperative rehabilitation affect positively for the outcome of surgery and QOL in surgical patients. However, in the HBP field, there are rarely studied for this concept. This study aim to investigate that the application of rehabilitation program for the surgery of HBP malignancies affect on short-term outcome and lead the improvement of QOL.

Interventions

BEHAVIORALPerioperative rehabilitation program

Perioperative rehabilitation program * preoperative rehabilitation : 2 weeks prior to operation * postoperative rehabilitation : 3 months after operation

BEHAVIORALConventional

conventional perioperative management without rehabilitation program

Sponsors

Asan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Masking description

The result of allocation in control and intervention group would be blinded to primary and secondary outcomes assessor.

Intervention model description

2 arm, parallel, randomized controlled study

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* \>18 years old or \<80 years old * ECOG 0-2 * resectable HBP malignancies or premalignant lesions which should be required GI resection and anastomosis * open surgery * no distant metastasis * no functional disturbance in bone marrow; WBC at least 3,000/mm3 or absolute neutrophil count at least 1,500/mm3, Platelet count at least 125,000/mm3 * no functional disturbance in liver; AST less than 5 times upper limit of normal * no function disturbance in kidney; Creatinine no greater than 1.5 times upper limit of normal * informed consent

Exclusion criteria

* distant metastasis (+) or recurred HBP tumor * active or uncontrolled infection * alcohol or other drug addiction * already enrolled patient in other study which affect this study * pregnant or the possibility of pregnancy (+) * uncontrolled cardiopulmonary disease * moderate to severe comorbidity which affect on the quality of life and nutritional status (liver cirrhosis, end stage renal disease, heart failure, etc.) * previous history of major gastrointestinal surgery (gastrectomy, colectomy, etc.) * previous history of neurological or musculoskeletal diseases which is impossible to allow investigator's order

Design outcomes

Primary

MeasureTime frameDescription
The incidence and severity of general complicationtill postoperative 3 monthsIncidence rate and severity of general complications except operation-specific complication, according to Clavien-Dindo classification

Secondary

MeasureTime frameDescription
The incidende of Mortalitytill postoperative 3 monthsRate of in-hospital mortality and 90 days mortality
Rate of re-admissiontill postoperative 3 monthsthe rate of re-admission, till postoperative 3 months
The changes in Quality of lifeComparison between at the time of discharge and postoperative 3monthschanges in quality of life (EORTC QLQ-C30), at the time of discharge and 3 months after surgery
The incidence of operation-specific complicationtill postoperative 3 monthsIncidence rate and severity of operation-specific complication, according to Clavien-Dindo classification
Measurement on 6 minutes walk test (m/minute) (Changes in the parameters of rehabilitation)Initial(2 weeks before surgery), preoperative (within 2days prior to surgery) and 3 months after surgeryMeasure the 6 minutes walk test (m/minute)
Grasping power(dynamometer, kg)(Changes in the parameters of rehabilitation)Initial(2 weeks before surgery), preoperative (within 2days prior to surgery) and 3 months after surgeryGrasping power measurement using dynamometer
Compliance of Aerobic exercise, strength exercise and respiratory excursion (Changes in the parameters of rehabilitation)Initial(2 weeks before surgery), preoperative (within 2days prior to surgery) and 3 months after surgeryCompliance of Aerobic exercise, strength exercise and respiratory excursion based on exercise diary

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026